Emergency Helpline: 8000 7070+97332181810MyKIMS Login
KIMS Royal Bahrain Hospital

Doctors & Specialities

Explore all Doctors
Explore all Specialities
Explore all Diseases and Conditions
Explore all Procedures
Emergency Helpline: 8000 7070+97332181810Patient StoriesKIMSHEALTH Seha Card

Packages & Services

Explore all Health Packages
Insurance Partner
Explore all Health Services
Emergency Helpline: 8000 7070+97332181810Patient StoriesKIMSHEALTH Seha Card
|
Royal Bahrain Hospital, Salmaniya
RBH Medical Center, Janabiyah
Who We Are
Contact Us
Quality & Accreditations
Leadership
Media & Newsroom
Our Network
Emergency Helpline: 8000 7070+97332181810Patient StoriesKIMSHEALTH Seha Card
Emergency: 8000 7070 +97332181810
  • Explore all DoctorsExplore all SpecialitiesExplore all Diseases and ConditionsExplore all Procedures
  • Explore all Health PackagesInsurance PartnerExplore all Health Services
  • Our Facilities

    Royal Bahrain Hospital, SalmaniyaRBH Medical Center, Janabiyah

    About Us

    Who We AreContact UsQuality & AccreditationsLeadershipMedia & NewsroomOur Network
Emergency Helpline: 8000 7070+97332181810Patient StoriesKIMSHEALTH Seha Card
HomeProceduresThyroid Uptake and Scan

Thyroid Uptake and Scan

Care Before the Procedure

  • Preparation:
    • Fasting: Avoid food and drinks for 2–4 hours before tracer administration (check facility guidelines).
    • Medication Hold: Stop thyroid medications (e.g., levothyroxine, methimazole) as directed—usually 1–4 weeks prior.
    • Iodine Restrictions: Avoid iodine-rich foods (e.g., seafood, iodized salt), supplements, and contrast media for 2–6 weeks.
    • Health Disclosure: Inform staff if you are pregnant, breastfeeding, or taking lithium, amiodarone, or thyroid hormones.
    • Tracer Administration: Swallow a tasteless capsule or liquid containing the radioactive tracer.

Care During the Procedure

  • Uptake Measurement (6–24 hours post-tracer):
    • A painless gamma probe is placed near the neck for 1–5 minutes to measure radioactivity.
  • Scan (after uptake or separately):
    • You lie still on a table while a gamma camera rotates around your neck, capturing images for 20–30 minutes.
  • Patient Experience:
    • No pain or discomfort; you must remain still during imaging.
    • Radiation exposure is low and considered safe for non-pregnant adults.

Care After the Procedure

  • Radiation Safety:
    • Drink plenty of fluids to flush out the tracer.
      Avoid close contact with pregnant women and infants for 24–48 hours.
  • Results:
    • Uptake Value: High uptake suggests hyperthyroidism (e.g., Graves’ disease); low uptake indicates hypothyroidism or thyroiditis.
    • Scan Findings:
    • “Hot” nodules (high tracer uptake) are rarely cancerous.
    • “Cold” nodules (low uptake) may require further evaluation (e.g., biopsy).
    • Results are interpreted by a nuclear medicine physician and shared by your referring doctor.
  • Follow-Up:
    • Abnormal results may lead to:
      Medication adjustments.
    • Radioactive iodine therapy for hyperthyroidism.
    • Ultrasound or biopsy for suspicious nodules.
  • Resume Normal Activities:
    • Restart thyroid medications as advised.
    • No dietary restrictions after the test.
  • Note: This test requires careful preparation to avoid false results. Always follow your facility’s instructions precisely. While radiation exposure is minimal, it is not suitable for pregnant or breastfeeding patients. Alternative tests (e.g., thyroid ultrasound) may be used if contraindicated.

Eligibility

  • This test is typically ordered for patients with:
    Abnormal thyroid hormone levels (e.g., high TSH, low T4/T3) or symptoms of thyroid dysfunction.
  • Thyroid nodules found on physical exam or ultrasound.
  • Suspected Graves’ disease, toxic nodules, or thyroiditis.
  • History of thyroid cancer requiring evaluation.
  • Preparation:
    • Fasting: Avoid food and drinks for 2–4 hours before tracer administration (check facility guidelines).
    • Medication Hold: Stop thyroid medications (e.g., levothyroxine, methimazole) as directed—usually 1–4 weeks prior.
    • Iodine Restrictions: Avoid iodine-rich foods (e.g., seafood, iodized salt), supplements, and contrast media for 2–6 weeks.
    • Health Disclosure: Inform staff if you are pregnant, breastfeeding, or taking lithium, amiodarone, or thyroid hormones.
    • Tracer Administration: Swallow a tasteless capsule or liquid containing the radioactive tracer.
  • Uptake Measurement (6–24 hours post-tracer):
    • A painless gamma probe is placed near the neck for 1–5 minutes to measure radioactivity.
  • Scan (after uptake or separately):
    • You lie still on a table while a gamma camera rotates around your neck, capturing images for 20–30 minutes.
  • Patient Experience:
    • No pain or discomfort; you must remain still during imaging.
    • Radiation exposure is low and considered safe for non-pregnant adults.
  • Radiation Safety:
    • Drink plenty of fluids to flush out the tracer.
      Avoid close contact with pregnant women and infants for 24–48 hours.
  • Results:
    • Uptake Value: High uptake suggests hyperthyroidism (e.g., Graves’ disease); low uptake indicates hypothyroidism or thyroiditis.
    • Scan Findings:
    • “Hot” nodules (high tracer uptake) are rarely cancerous.
    • “Cold” nodules (low uptake) may require further evaluation (e.g., biopsy).
    • Results are interpreted by a nuclear medicine physician and shared by your referring doctor.
  • Follow-Up:
    • Abnormal results may lead to:
      Medication adjustments.
    • Radioactive iodine therapy for hyperthyroidism.
    • Ultrasound or biopsy for suspicious nodules.
  • Resume Normal Activities:
    • Restart thyroid medications as advised.
    • No dietary restrictions after the test.
  • Note: This test requires careful preparation to avoid false results. Always follow your facility’s instructions precisely. While radiation exposure is minimal, it is not suitable for pregnant or breastfeeding patients. Alternative tests (e.g., thyroid ultrasound) may be used if contraindicated.
  • This test is typically ordered for patients with:
    Abnormal thyroid hormone levels (e.g., high TSH, low T4/T3) or symptoms of thyroid dysfunction.
  • Thyroid nodules found on physical exam or ultrasound.
  • Suspected Graves’ disease, toxic nodules, or thyroiditis.
  • History of thyroid cancer requiring evaluation.

More from KIMSHEALTH

Looking for something else?

Insurance Partners

Insurance Partners

Health Packages

Health Packages

KIMSHEALTH App

KIMSHEALTH App

Footer Background
Footer Logo

Our Facilities

  • Salmaniya (Hospital)
  • Janabiyah (Medical Centre)

Specialities

Contact Us

Plan Your Visit

  • Find a Doctor
  • Find Insurance Partner
  • KIMSHEALTH Seha Card

Packages & Services

  • Health Packages
  • Health at Home
  • Dialysis
  • Maternity Packages

Support

  • Patient & Visitor FAQs
  • Regional Sitemap

Health Library

Careers

  • Life at KIMSHEALTH
  • Job Listings

Smartphone-Free Childhood Bahrain

ACCN Course Payment

Copyright © 2026. KIMSHEALTH. All Rights Reserved

Instagram IconFacebook IconSnapchat IconTiktok Icon

Download the App

Google PlayApp Store